رجوع
34
2
نطاق اليوم
KWD 18.17
KWD 20.43
نطاق 52 أسبوعًا
KWD 14.09
KWD 21.22
حجم التداول
24
متوسط 50 يوم / 200 يوم
KWD 18.17
/
KWD 19.03
الإغلاق السابق
KWD 18.17
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 10.6 | 3.9 |
| Net Margin % | 5.2 | 3.8 |
| Rev Growth 5Y % | 17.5 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 195.59
KWD 191.17 – KWD 199.53
|
1.26T | 1 |
| FY2029 |
KWD 185.85
KWD 181.64 – KWD 189.59
|
1.23T | 1 |
| FY2028 |
KWD 162.15
KWD 158.48 – KWD 165.42
|
1.21T | 1 |
No quarterly estimates available
Dividend History
Yield
0.02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 17.50% annually over 5 years — strong growth
ROE of 10.56% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 67.01B in free cash flow
P/E of 0.13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.68%
النمو
Revenue Growth (5Y)
17.50%
Revenue (1Y)3.82%
Earnings (1Y)4.45%
FCF Growth (3Y)19.01%
الجودة
Return on Equity
10.56%
ROIC11.77%
Net Margin5.15%
Op. Margin7.73%
الأمان
Debt / Equity
0.00
Current Ratio2.24
Interest Coverage1282.53
التقييم
P/E Ratio
0.13
Forward P/EN/A
P/B Ratio0.01
EV/EBITDA-1.25
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.82% | Revenue Growth (3Y) | 5.64% |
| Earnings Growth (1Y) | 4.45% | Earnings Growth (3Y) | 16.13% |
| Revenue Growth (5Y) | 17.50% | Earnings Growth (5Y) | 26.13% |
| Profitability | |||
| Revenue (TTM) | 1.06T | Net Income (TTM) | 54.68B |
| ROE | 10.56% | ROA | 7.67% |
| Gross Margin | 35.06% | Operating Margin | 7.73% |
| Net Margin | 5.15% | Free Cash Flow (TTM) | 67.01B |
| ROIC | 11.77% | FCF Growth (3Y) | 19.01% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.24 |
| Interest Coverage | 1282.53 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.13 | Forward P/E | N/A |
| P/B Ratio | 0.01 | P/S Ratio | 0.01 |
| PEG Ratio | 2.32 | Forward PEG | N/A |
| EV/EBITDA | -1.25 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 926.84% | ||
| Market Cap | 7.23B | Enterprise Value | -102.31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.06T | 1.02T | 951.25B | 729.97B | 556.91B |
| Net Income | 54.68B | 52.35B | 40.55B | 34.38B | 21.60B |
| EPS (Diluted) | 133.81 | 125.27 | 95.99 | 93.78 | 70.12 |
| Gross Profit | 372.24B | 331.80B | 329.32B | 240.30B | 182.10B |
| Operating Income | 82.08B | 75.71B | 62.28B | 41.41B | 31.53B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 712.78B | 724.75B | 688.13B | 656.74B | 368.92B |
| Total Liabilities | 191.28B | 209.57B | 205.42B | 192.40B | 122.46B |
| Shareholders' Equity | 520.80B | 514.73B | 482.47B | 464.32B | 246.46B |
| Total Debt | 2.21B | 20.66B | 21.41B | 22.92B | 23.70B |
| Cash & Equivalents | 111.75B | 117.72B | 95.22B | 74.52B | 38.52B |
| Current Assets | 364.32B | 370.80B | 329.81B | 304.39B | 175.70B |
| Current Liabilities | 162.64B | 179.43B | 153.27B | 142.45B | 84.89B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#581 of 827
#683 of 709
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026